相关实验视频
Updated: Jul 13, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
对帕金森病的立体分期不对称双边射频损伤
1Department of Functional Neurosurgery and Neuromodulation, SI "Romodanov Neurosurgery Institute NAMS of Ukraine", Kyiv, Ukraine.
Stereotactic and functional neurosurgery
|October 16, 2023
概括
在帕金森病患者中,分阶段双边射频损伤显著改善了运动症状. 这种立体性除提供了一个安全有效的替代品,当深度大脑刺激不适合时.
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 医疗器械 医疗器械
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病.
- 立体性损伤是PD的重要治疗方法,补充神经刺激.
- 射频 (RF) 损伤提供了一个替代的治疗方法.
研究的目的:
- 为了评估分阶段双边不对称的射频立体性损伤的有效性和安全性.
- 评估高度精选的高级PD患者组的结果.
- 为了比较全球内核 (GPi) 与亚体核 (STN) 的损伤.
主要方法:
- 对28名PD患者进行分阶段不对称双边切除术的回顾性审查.
- 初始的射频瘤切除术,其次是对侧瘤切除术 (Vim-GPi) 或底核 (STN) 损伤 (Vim-STN).
- 长期随访 (平均4.8年) 评估第二次手术后1年.
主要成果:
- 显著的运动症状改善:震 (81%),刚性 (66%),低运动 (40%).
- 在Vim-GPi和Vim-STN组中,总的UPDRS得分提高了44-51%.
- 利沃多巴剂量减少了43.4%;14.3%的人出现神经复杂症,3.6%的人患有永久性缺血症.
结论:
- 渐进的非对称双边射频损伤对于精选的晚期PD患者来说是安全有效的.
- 这种方法特别有用,当深度大脑刺激是不可用的或不必要时.
- 仔细的患者选择对于PD治疗的最佳结果至关重要.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.8K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.9K
相关概念视频
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567